Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2007 3
2008 4
2009 6
2010 9
2011 10
2012 6
2013 7
2014 8
2015 7
2016 2
2017 4
2018 6
2019 8
2020 6
2021 3
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodríguez Alvarez FM, Castillo Laguarta JM, Del Estad Cabello A, Gessa Sorroche M, España Gregori E, Sales-Sanz M; Tocilizumab in Graves Orbitopathy Study Group. Perez-Moreiras JV, et al. Among authors: perez pampin e. Am J Ophthalmol. 2018 Nov;195:181-190. doi: 10.1016/j.ajo.2018.07.038. Epub 2018 Aug 4. Am J Ophthalmol. 2018. PMID: 30081019 Clinical Trial.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Lumbalgia de un año de evolución.
Pérez Pampín E, Campos Franco J, Villalón Blanco J, Díaz Garel JJ. Pérez Pampín E, et al. Reumatol Clin. 2008 Jan;4(1):32-3. doi: 10.1016/S1699-258X(08)71792-3. Epub 2008 Oct 28. Reumatol Clin. 2008. PMID: 21794491 Free article. Spanish. No abstract available.
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study.
Joven B, Hernández Sánchez R, Pérez-Pampín E, Aragón Díez Á, Almodóvar R, Martínez-Ferrer Á, Belzunegui J, Rubio E, Díaz-Cerezo S, Moyano S, Gómez-Barrera M, Yébenes M, Núñez M. Joven B, et al. Among authors: perez pampin e. Rheumatol Ther. 2023 Oct;10(5):1319-1333. doi: 10.1007/s40744-023-00584-8. Epub 2023 Jul 23. Rheumatol Ther. 2023. PMID: 37481752 Free PMC article.
[Cat-scratch disease].
Campos Franco J, Mallo González N, López Rodríquez R, Pérez Pampín E. Campos Franco J, et al. Among authors: perez pampin e. Med Clin (Barc). 2007 Sep 8;129(8):320. doi: 10.1016/s0025-7753(07)72839-7. Med Clin (Barc). 2007. PMID: 17969956 Spanish. No abstract available.
Objectives and methodology of BIOBADASER phase iii.
Sanchez-Piedra C, Hernández Miguel MV, Manero J, Roselló R, Sánchez-Costa JT, Rodríguez-Lozano C, Campos C, Cuende E, Fernández-Lopez JC, Bustabad S, Martín Domenech R, Pérez-Pampín E, Del Pino-Montes J, Millan-Arciniegas AM, Díaz-González F, Gómez-Reino JJ; en representación del Grupo de trabajo BIOBADASER Fase III. Sanchez-Piedra C, et al. Among authors: perez pampin e. Reumatol Clin (Engl Ed). 2019 Jul-Aug;15(4):229-236. doi: 10.1016/j.reuma.2017.08.001. Epub 2017 Sep 19. Reumatol Clin (Engl Ed). 2019. PMID: 28935290 Free article. English, Spanish.
Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis.
Rodríguez-Martínez L, Regueiro C, Amhaz-Escanlar S, Pena C, Herbello-Hermelo P, Moreda-Piñeiro A, Rodriguez-Garcia J, Mera-Varela A, Pérez-Pampín E, González A. Rodríguez-Martínez L, et al. Among authors: perez pampin e. Diagnostics (Basel). 2022 Jan 29;12(2):352. doi: 10.3390/diagnostics12020352. Diagnostics (Basel). 2022. PMID: 35204444 Free PMC article.
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Fernández-Espartero MC, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group. Fernández-Espartero MC, et al. Semin Arthritis Rheum. 2011 Feb;40(4):330-7. doi: 10.1016/j.semarthrit.2010.06.004. Epub 2010 Sep 22. Semin Arthritis Rheum. 2011. PMID: 20864146 Review.
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Cruz Fernández-Espartero M, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group. Cruz Fernández-Espartero M, et al. Semin Arthritis Rheum. 2011 Dec;41(3):524-33. doi: 10.1016/j.semarthrit.2011.05.003. Semin Arthritis Rheum. 2011. PMID: 22152489 Review.
Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice.
Gomollón F, Seoane-Mato D, Montoro MA, Juanola X, Trujillo-Martin E, Carrillo-Palau M, Matallana V, García-Magallón B, Ber Y, Ramos L, Perez-Pampin E, Ferreiro-Iglesias R, Rodríguez-Alonso L, Marco-Pascual C, Sanz Sanz J; Validación-PIIASER Study Group. Gomollón F, et al. Among authors: perez pampin e. Dig Liver Dis. 2022 Jun;54(6):755-762. doi: 10.1016/j.dld.2021.12.010. Epub 2022 Jan 14. Dig Liver Dis. 2022. PMID: 35039222
90 results